INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2014
Net Assets |
£191m |
Net Assets per share |
351p |
Share price |
290p |
Total value of unquoted investments |
£18m |
Total number of portfolio companies |
90 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
9.6 |
Biogen |
7.7 |
Alexion |
7.6 |
Celgene |
7.0 |
Amgen |
6.1 |
Vertex |
5.0 |
Illumina |
3.9 |
Mylan |
3.6 |
Biomarin |
3.2 |
Chimerix |
2.9 |
|
----------- |
Total |
56.6 |
Portfolio Profitability |
% NAV |
Profitable |
63 |
Turning Profitable 2015 |
9 |
Unprofitable |
28 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
88 |
Europe & UK |
12 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
91 |
Unquoted |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
29 AUGUST 2014